XTX Topco Ltd

Position in GMAB — Genmab A/S

CIK 1828301 LONDON, X0

Position in GMAB

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,253,202

+$156,815 QoQ

Shares Held

46,709

+31.2% QoQ

Ownership

0.008%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

10 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

XTX Topco Ltd holds $287,762,779 across 374 Biotechnology names. GMAB ranks #70 (0.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	255,431	$7,075,438
2	VRTX	Vertex Pharmaceuticals Inc / Ma	15,632	$6,980,313
3	IONS	Ionis Pharmaceuticals Inc	80,519	$6,046,171
4	EXEL	Exelixis, Inc.	134,413	$5,764,973
5	NUVL	Nuvalent, Inc.	53,354	$5,466,117
6	AGIO	Agios Pharmaceuticals, Inc.	160,880	$5,442,570
7	BMRN	Biomarin Pharmaceutical Inc	93,609	$5,287,972
8	RYTM	Rhythm Pharmaceuticals, Inc.	59,502	$5,174,888

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,253,202	46,709	+31.2%	Shares	Defined	2026-05-15
2025-12-31	$1,096,387	35,597	+16.5%	Shares	Defined	2026-02-17
2025-09-30	$936,845	30,546	-1.2%	Shares	Defined	2025-11-14
2025-03-31	$605,589	30,929	+21.6%	Shares	Defined	2025-05-08
2024-09-30	$619,959	25,429	+116.4%	Shares	Defined	2024-11-14
2024-06-30	$295,302	11,751	-47.7%	Shares	Defined	2024-08-12
2024-03-31	$671,658	22,456	+76.7%	Shares	Defined	2024-05-13
2023-12-31	$404,559	12,706	+16.3%	Shares	Defined	2024-02-13
2022-12-31	$462,831	10,921	+114.6%	Shares	Defined	2023-02-14
2021-06-30	$207,783	5,089	—	Shares	Defined	2021-08-12
No filing history on record for this holder in this stock.